Unknown PHASE3 INTERVENTIONAL 4-arm NCT03054168

Systemic Hormones and Muscle Protein Synthesis

The Regulation of Skeletal Muscle Protein Synthesis by Systemic Hormones and Its Influence on Ageing and Anabolic Resistance

Sponsor: University of Nottingham

Conditions Muscle Atrophy Muscle Hypotrophy Sarcopenia

Interventions Placebo Sustanon 250 Zoladex

Updated 7 times since 2017 Last updated: Feb 22, 2019 Started: Dec 15, 2016 Primary completion: Nov 15, 2018 Completion: Feb 15, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Muscle Atrophy and Muscle Hypotrophy and is currently ongoing. University of Nottingham leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Active Not Recruiting PHASE3
Mar 2019 — Jan 2021 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE3
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Nottingham

Data source: University of Nottingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Derby, United Kingdom